I67.3
Progressive vascular leukoencephalopathy
Clinical Classification Guidelines
Inclusion Terms
- Binswanger's disease
Medical Intelligence & Overview
Progressive vascular leukoencephalopathy, also known as Binswanger’s disease, is a type of small vessel disease affecting the brain's white matter. It results from chronic damage to the small blood vessels, leading to degenerative changes in the brain tissue. This condition predominantly affects older adults and can cause a variety of neurological problems, particularly related to cognition and movement.
Causes & Symptoms
Clinical Causes: Chronic hypertension (long-standing high blood pressure) Atherosclerosis (hardening of the arteries) Diabetes mellitus Smoker's exposure to toxins Advanced age History of stroke or transient ischemic attacks (TIAs) Other conditions that impair blood vessel integrity
Key Symptoms: Gradual cognitive decline, including memory problems and confusion Changes in personality or behavior Impaired executive functions, such as planning and problem-solving Unsteady gait or difficulty walking Urinary incontinence Lack of coordination and weakness in limbs Lesions may develop slowness or difficulty in speech
Diagnostic & Treatment
Diagnosis Path: Diagnosis of progressive vascular leukoencephalopathy involves a combination of clinical assessment, neurological examination, and neuroimaging studies. Magnetic resonance imaging (MRI) is the preferred imaging technique, revealing characteristic white matter lesions and small infarcts. Laboratory tests might be used to rule out other causes of similar symptoms, such as infections or tumors. A detailed patient history focusing on vascular risk factors aids diagnosis.
Treatment Protocols: While there is no specific cure for Binswanger’s disease, management aims to control underlying risk factors and slow progression. Treatment strategies include:
Clinical Advice & FAQs
Billing Guidance
Is I67.3 a billable ICD-10 code?
Yes, I67.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report I67.3?
Clinical documentation must specify the nature of Progressive vascular leukoencephalopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference